This Biotech Fund Sold $8 Million, Yet Remains Bullish on Terns
A biotech fund reduced its Terns Pharmaceuticals position by about $8 million last quarter. Despite the sale, the the...
Utilize diversification as a key strategy for wealth preservation. Safeguard your investments against market fluctuations.
23,542 articlesA biotech fund reduced its Terns Pharmaceuticals position by about $8 million last quarter. Despite the sale, the the...
Cloudflare shares climbed about 8% on the day as investors bet NVIDIA’s AI acceleration will push more traffic throug...
Palantir's journey has been a roller coaster—massive gains, sharp pulls, and ongoing questions. This guide distills w...
Federal Reserve Chair Jerome Powell acknowledges that AI-driven data-center expansion is lifting consumer costs in th...
Zcash slid roughly 15% in 48 hours, pushing toward $230 as a classic reversal pattern took hold and market sentiment ...
Hess Midstream’s capital return program is under review as a $60 million buyback coincides with a high payout ratio a...
Microvast’s Q4 2025 results trigger a sharp pullback in mvst stock down this year. A $32.5 million inventory impairme...
Public life tests more than reputations—it tests money boundaries too. This article uses the phrase 'mayor kept calli...
As hurricane risk and losses climb, lenders are expanding financing options for these round homes resilient designs, ...
Freshworks unveils a $400 million share repurchase as it shifts to AI-based pricing, prompting investor debate over w...
Quantum computing is moving from theory to real-world use. In this guide, we break down the three best quantum comput...
U.S. prosecutors allege a scheme to move Nvidia GPUs and servers to China, with Supermicro’s co-founders at the cente...